Reported Jun 30, 2021 · Terminated
Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx only, Manufactured by: Cadila Healthcare…
Viona Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: VIONA PHARMACEUTICALS INC · 20 Commerce Dr Ste 340 · Cranford, NJ · 07016-3617
Is this the product you have?
- Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx only
- Manufactured byCadila Healthcare Ltd. Ahmedabad, India
- Distributed byViona Pharmaceuticals Inc. Cranford, NJ 07016 NDC 72578-036-01
- Lot codes and dates
Lot M915601 & M915602Oct 2021
- Amount recalled
- 21240 bottles
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Viona Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.